Caxton Associates (New York)’s Abbott ABT Stock Holding History

Caxton Associates (New York)’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,457	Closed	-$491K	–	449
2023 Q4	$491K	Sell	4,457 -8,944	-67%	-$894K	0.03%	328
2023 Q3	$1.3M	Buy	13,401 +844	+7%	+$88.6K	0.18%	107
2023 Q2	$1.37M	Sell	12,557 -8,585	-41%	-$915K	0.2%	111
2023 Q1	$2.14M	Buy	+21,142	New	+$2.23M	0.32%	44
2022 Q4	–	Sell	-6,274	Closed	-$607K	–	436
2022 Q3	$607K	Buy	6,274 +605	+11%	+$64.5K	0.08%	201
2022 Q2	$616K	Buy	+5,669	New	+$644K	0.06%	224
2019 Q4	–	Sell	-4,401	Closed	-$367K	–	389
2019 Q3	$367K	Sell	4,401 -1,914	-30%	-$163K	0.07%	204
2019 Q2	$531K	Buy	6,315 +3,042	+93%	+$239K	0.06%	182
2019 Q1	$262K	Buy	+3,273	New	+$244K	0.04%	287
2018 Q3	–	Sell	-18,108	Closed	-$1.1M	–	390
2018 Q2	$1.1M	Buy	+18,108	New	+$1.1M	0.06%	157

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Caxton Associates (New York)'s ABT Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Abbott (ABT) in Q1 2024, closing a stake of 4,457 shares — an estimated $491K sold.

Caxton Associates (New York) first reported a position in ABT in Q2 2018 and held it in 10 quarters. The position peaked at $2.14M in Q1 2023. 2,904 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

Caxton Associates (New York) reported no remaining Abbott position as of Q1 2024 after selling out during the quarter.
Caxton Associates (New York) sold 4,457 Abbott shares in Q1 2024, an estimated $491K.
Caxton Associates (New York) first reported a position in Abbott in Q2 2018 and held it in 10 quarters.
Caxton Associates (New York)'s Abbott position peaked at $2.14M in Q1 2023.
2,904 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.